Evidence map›Paper›PMID 36144522›Full record

ArticleMolecules (Basel, Switzerland)2022

Evaluation of Hypoglycemic Activity and Sub-Acute Toxicity of the Novel Biochanin A-Chromium(III) Complex.

Pengshou Li, Mengdan Li, Xinhua Lou, Baosheng Zhao, Qixiang Ma, Yumiao Bian, Xiliang Mi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Effects of dietaryFrontiers in veterinary science · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pengshou LiSchool of Food and Drug, Luoyang Normal University, Luoyang 471934, China.
Mengdan LiSchool of Food and Drug, Luoyang Normal University, Luoyang 471934, China.
Xinhua LouSchool of Food and Drug, Luoyang Normal University, Luoyang 471934, China.
Baosheng ZhaoBeijing Academy of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Qixiang MaCancer Institute, Fudan University Cancer Hospital and Cancer Metabolism Laboratory, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
Yumiao BianSchool of Food and Drug, Luoyang Normal University, Luoyang 471934, China.
Xiliang MiSchool of Food and Drug, Luoyang Normal University, Luoyang 471934, China.

Funding

Key Scientific Research Projects of Henan Province Colleges and Universities 20B360016National Project Cultivation Fund of Luoyang Normal University 2019-PYJJ-013PhD Research Foundation of Luoyang Normal University 4600210Special Project of Henan Provincial Key Research, Development and Promotion (Science and Technology) 212102311104
6 · The paper itself

Abstract

The novel biochanin A-chromium(III) complex was synthesized by chelating chromium with biochanin A (BCA). The structure of the complex was determined and the complex ([CrBCA

Indexed as

Diabetes Mellitus, ExperimentalInsulinsAnimalsAntioxidantsBlood GlucoseChromiumGenisteinGlycogenHypoglycemic AgentsInsulinMiceAntioxidantsbiochanin ABlood GlucoseChromiumGenisteinGlycogenHypoglycemic AgentsInsulinInsulinsbiochanin Achromium complexhypoglycemic activitysub-acute toxicity

Identifiers

PMID36144522
PMCPMC9504010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.